Hepatocellular Carcinoma Caused by Hepatitis B Virus

  • Joseph L. Melnick
Chapter

Abstract

Although hepatocellular carcinoma (HCC) is rare in Europe and North America, it is very common in many areas of the world, including Africa and Southeast Asia, where it is among the ten most common human cancers. It is estimated that there are more than 250,000 new patients with liver cancer each year. Over 30 new cases of hepatoma occur per 100,000 population annually in the high–prevalence areas, but the yearly incidence is less than five per 100,000 in most countries of North America, Europe, and Australia. Hepatocellular carcinoma is more common in males than among females. Its prevalence increases with age, although in high-risk populations, the disease also occurs in younger age groups.

Keywords

Hepatitis Urea Europe Lymphoma Aflatoxin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Arevalo, J. A., and Washington, A. E., Cost-effectiveness of prenatal screening and immunization for hepatitis B virus,J.A.M.A. 259: 365 – 369 (1988).CrossRefGoogle Scholar
  2. 2.
    Beasley, R. P., Hepatitis B virus as the etiologic agent in hepatocellular carcinoma—epidemiologic considerations,Hepatology 2:21S–26S (1982).Google Scholar
  3. 3.
    Beasley, R. P., and Hwang, L.-Y., Epidemiology of hepatocellular carcinoma, in:Viral Hepatitis and Liver Disease(G. N. Vyas, J. L. Dienstag, and J. H. Hoofnagle, eds.), pp. 209 – 224, Grune & Stratton, Orlando, FL, 1984.Google Scholar
  4. 4.
    Beasley, R. P., Hwang, L.-Y., Lin, C.-C., and Chien, C.-S., Hepatocellular carcinoma and hepatitis B virus: A prospective study of 22,707 men in Taiwan,Lancet 2: 1129 – 1133 (1981).CrossRefGoogle Scholar
  5. 5.
    Beasley, R. P., Hwang, L.-Y., Stevens, C. E., Lin, C.-C., Hsieh, F.-J., Wang, K.-Y., Sun, T. S., and Szmuness, W., Efficacy of hepatitis B immune globulin for prevention of perinatal transmission of the hepatitis B virus carrier state: Final report of a randomized double-blind, placebo-controlled trial,Hepatology 3: 135 – 141 (1983).CrossRefGoogle Scholar
  6. 6.
    Beasley, R. P., Trepo, C., Stevens, C. E., and Szmuness, W., The e antigen and vertical transmission of hepatitis B surface antigen,Am. J. Epidemiol 105: 94 – 98 (1977).Google Scholar
  7. 7.
    Blumberg, B. S., and London, W. T., Hepatitis B virus and primary hepatocellular carcinoma: Relationship of “icrons” to cancer, in:Viruses in Naturally Occurring Cancers(M. Essex, Todaro, and H. zur Hausen, eds.), pp. 401 – 421, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, 1980.Google Scholar
  8. 8.
    Blumberg, B. S., and London, W. T., Hepatitis B virus and the prevention of primary cancer of the liver,J. Natl. Cancer Inst. 74: 267 – 273 (1985).Google Scholar
  9. 9.
    Brechot, C., Pourcel, C., Louise, A., Rain, B., and Tiollais, P., Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma,Nature 286: 533 – 535 (1980).CrossRefGoogle Scholar
  10. 10.
    Chen, D. S., Hoyer, B. H., Nelson, J., Purcell, R. H., and Gerin, J. L., Detection and properties of hepatitis B viral DNA in liver tissues from patients with hepatocellular carcinoma,Hepatology 2:42S–46S (1982).Google Scholar
  11. 11.
    Cutler, S. J., and Young, J. L., Jr., Third National Cancer Survey. Incidence data, in:NCI Monograph 41, DHEW Publication No. (NIH) 75 – 785, NCI, Bethesda, MD, 1975.Google Scholar
  12. 12.
    Dejean, A., Bougueleret, L., Grzeschik, K.-H., and Tiollais, P., Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinoma,Nature 322: 70 – 72 (1986).CrossRefGoogle Scholar
  13. 13.
    Dejean, A., Brechot, C., Tiollais, P., and Wain-Hobson, S., Characterization of integrated hepatitis B viral DNA cloned from a human hepatoma and the hepatoma-derived cell line PLC/PRF/5,Proc. Natl. Acad. Sci. U.S.A. 80: 2505 – 2509 (1983).CrossRefGoogle Scholar
  14. 14.
    Dejean, A., Sonigo, P., Wain-Hobson, S., and Tiollais, P., Specific hepatitis B virus integration in hepatocellular carcinoma DNA through a viral 11-base-pair direct repeat,Proc. Natl. Acad. Sci. U.S.A. 81: 5350 – 5354 (1984).CrossRefGoogle Scholar
  15. 15.
    de Thé, H., Marchio, A., Tiollais, P., and Dejean, A., A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma,Nature 330: 667 – 670 (1987).CrossRefGoogle Scholar
  16. 16.
    Ganem, D., and Varmus, H. E., The molecular biology of the hepatitis B viruses,Annu. Rev. Biochem. 56: 651 – 693 (1987).CrossRefGoogle Scholar
  17. 17.
    Gerin, J. L., Tennant, B. C., Ponzetto, A., Purcell, R., and Tyeryar, F. J., The woodchuck animal model of hepatitis B-like virus infection and disease,Prog. Clin. Biol. Res. 143: 23 – 28 (1983).Google Scholar
  18. 18.
    Goudeau, A., Maupas, P., Coursaget, P., Drucker, J., Chiron, J.-P., Denis, F., Mar, I. D., and N’Diaye, P. D., Detection of hepatitis B virus antigens in hepatocellular carcinoma tissues,Prog. Med. Virol. 27: 77 – 87 (1981).Google Scholar
  19. 19.
    Harrison, T. J., Chen, J.-Y., and Zuckerman, A. J., Hepatitis B and primary liver cancer, in:Cancer Treatment Reviews, vol. 13 (K. Hellmann and S. K. Carter, eds.), pp. 1 – 16, Academic Press, London, 1986.Google Scholar
  20. 20.
    Hino, O., Kitagawa, T., Koike, K., Kobayashi, M., Hara, M., Mori, W., Nakashima, T., Hattori, N., and Sugano, H., Detection of hepatitis B virus DNA in hepatocellular carcinomas in Japan,Hepatology 4: 90 – 95 (1984).CrossRefGoogle Scholar
  21. 21.
    Kane, M. A., Hadler, S. C., Margolis, H. S., and Maynard, J. E., Routine prenatal screening for hepatitis B surface antigen,J.A.M.A. 259: 408 – 409 (1988).CrossRefGoogle Scholar
  22. 22.
    Koshy, R., Koch, S., VonLoringhoven, A. F., Kahmann, R., Murray, K., and Hofschneider, P. H., Integration of hepatitis B virus DNA: Evidence for integration in the single-stranded gap,Cell 34: 215 – 223 (1983).CrossRefGoogle Scholar
  23. 23.
    Larouze, B., London, W. T., Saimot, G., Werner, B. G., Lustbader, E. D., Payet, M., and Blumberg, B. S., Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families: a case-control study in Senegal, West Africa,Lancet 2: 534 – 538 (1976).CrossRefGoogle Scholar
  24. 24.
    Lee, T.-H., and Butel, J. S., Transactivation of the HBV enhancer by the X gene of HBV, in:Abstracts of the Conference on Hepatitis B Viruses, p. 19, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1987.Google Scholar
  25. 25.
    Marion, P. L., Use of animal models to study hepatitis B virus,Prog. Med. Virol. 35: 43 – 75 (1988).Google Scholar
  26. 26.
    Marion, P. L., Knight, S. S., Salazar, F. H., Popper, H., and Robinson, W. S., Ground squirrel hepatitis virus infection,Hepatology 3: 519 – 527 (1983).CrossRefGoogle Scholar
  27. 27.
    Marion, P. L., Oshiro, L. S., Regnery, D. C., Scullard, G. H., and Robinson, W. S., A virus in Beechey ground squirrels that is related to hepatitis B virus of humans,Proc. Natl. Acad. Sci. U.S.A. 77: 2941 – 2945 (1980).CrossRefGoogle Scholar
  28. 28.
    Marion, P. L., and Robinson, W. S., Hepadna viruses: Hepatitis B and related viruses,Curr. Top. Microbiol. Immunol. 105: 91 – 121 (1983).Google Scholar
  29. 29.
    Marion, P. L., Van Davelaar, M. J., Knight, S. S., Salazar, F. H., Garcia, G., Popper, H., and Robinson, W. S., Hepatocellular carcinoma in ground squirrels persistently infected with ground squirrel hepatitis virus,Proc. Natl. Acad. Sci. U.S.A. 83: 4543 – 4546 (1986).CrossRefGoogle Scholar
  30. 30.
    Mason, W. S., Seal, G., and Summers, J., A virus of Pekin ducks with structural and biological relatedness to human hepatitis B virus,J. Virol. 36: 829 – 836 (1980).Google Scholar
  31. 31.
    Maupas, P., Chiron, J.-P., Goudeau, A., Coursaget, P., Perrin, J., Barin, F., Denis, F., and Mar, B. D., Active immunization against hepatitis B in an area of high endemicity. Part II: Prevention of early infection of the child,Prog. Med. Virol. 27: 185 – 201 (1981).Google Scholar
  32. 32.
    Maupas, P., and Melnick, J. L. (eds.), Hepatitis B virus and primary hepatocellular carcinoma,Prog. Med. Virol 27:1–210 (1981).Google Scholar
  33. Maupas, P., and Melnick, J. L., Hepatitis B infection and primary liver cancer,Prog. Med. Virol 27: 1 – 5 (1981).Google Scholar
  34. 34.
    McAuliffe, V. J., Purcell, R. H., and Gerin, J. L., Type B hepatitis: A review of current prospects for a safe and effective vaccine,Rev. Infect. Dis. 2: 470 – 492 (1980).CrossRefGoogle Scholar
  35. 35.
    Melnick, J. L., Hepatitis B virus and liver cancer, in:Viruses Associated with Human Cancer(L. A. Phillips, ed.), pp. 337 – 367, Marcel Dekker, New York, 1983.Google Scholar
  36. 36.
    Melnick, J. L., and Ledinko, N., Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period. The ratio of inapparent infection to clinical poliomyelitis,Am. J. Hyg. 58: 207 – 222 (1953).Google Scholar
  37. 37.
    Miyaki, M., Sato, C., Gotanda, T., Matsui, T., Mishiro, S., Imai, M., and Mayumi, M., Integration of region X of hepatitis B virus genome in human primary hepatocellular carcinomas propagated in nude mice,J. Gen. Virol. 67: 1449 – 1454 (1986).CrossRefGoogle Scholar
  38. 38.
    Nerenberg, M., Hinrichs, S. H., Reynolds, R. K., Khoury, G., and Jay, G., Thetatgene of human T-lymphotropic virus type 1 induces mesenchymal tumors in transgenic mice,Science 237: 1324 – 1329 (1987).CrossRefGoogle Scholar
  39. 39.
    Nishioka, K., Levin, A. G., and Simons, M. J., Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease: Results of a collaborative study,Bull. WHO 52: 293 – 300 (1975).Google Scholar
  40. 40.
    Ochiya, T., Fujiyama, A., Fukushige, S., Hatada, I., and Matsubara, K., Molecular cloning of an oncogene from a human hepatocellular carcinoma,Proc. Natl. Acad. Sci. U.S.A. 83: 4993 – 4997 (1986).CrossRefGoogle Scholar
  41. 41.
    Okada, K., Kamiyama, I., Inomata, M., Imai, M., Miyakawa, Y., and Mayumi, M., E antigen and anti-e in the serum of asymptomatic carrier mothers as indicators of positive and negative transmission of hepatitis B virus to their infants,N. Engl. J. Med. 294: 746 – 749 (1976).CrossRefGoogle Scholar
  42. 42.
    Okada, K., and Beasley, R. P., Epidemiology of hepatocellular carcinoma,UICC Rep. 17:9–30 (1982).Google Scholar
  43. 43.
    Popper, H., Roth, L., Purcell, R. H., Tennant, B. C., and Gerin, J. L., Hepatocarcinogenicity of the woodchuck hepatitis virus,Proc. Natl. Acad. Sci. U.S.A. 84: 866 – 870 (1987).CrossRefGoogle Scholar
  44. 44.
    Popper, H., Shafritz, D. A., and Hoofnagle, J. H., Relation of the hepatitis B virus carrier state to hepatocellular carcinoma,Hepatology 7: 764 – 772 (1987).CrossRefGoogle Scholar
  45. 45.
    Popper, H., Shih, J. W. K., Gerin, J. L., Wong, D. C., Hoyer, B. H., London, W. T., Sly, D. L., and Purcell, R. H., Woodchuck hepatitis and hepatocellular carcinoma: Correlation of histologic with virologic observations,Hepatology 1: 91 – 98 (1981).CrossRefGoogle Scholar
  46. 46.
    Prince, A. M., Discussion, in:Viral Hepatitis(G. N. Vyas, S. N., Cohen, and R. Schmid, eds.), pp. 460 – 463, Franklin Institute Press, Philadelphia, 1978.Google Scholar
  47. 47.
    Prince, A. M., Hepatitis B virus and primary liver cancer, in:Accomplishments in Cancer Research(J. G. Fortner and J. E. Rhoads, eds.), pp. 110 – 118, J. B. Lippincott, Philadelphia, 1985.Google Scholar
  48. 48.
    Robinson, W. S., Hepatitis B virus, in:Virology(B. N. Fields, D. M. Knipe, R. M. Chanock, J. L., Melnick, B. Roizman, and R. E. Shope, eds.), pp. 1384 – 1406, Raven Press, New York, 1985.Google Scholar
  49. 49.
    Robinson, W. S., Marion, P., Feitelson, M., and Siddiqui, A., The hepadna virus group: Hepatitis B and related viruses, in:Viral Hepatitis—1981 International Symposium(W. Szmuness, H. J. Alter, and J. E. Maynard, eds.), pp. 57 – 68, Franklin Institute Press, Philadelphia, 1982.Google Scholar
  50. 50.
    Rogler, C. E., Sherman, M., Su, C. Y., Shafritz, D. A., Summers, J., Shows, T. B., Henderson, A., andKew, M., Deletion in chromosome lip associated with a hepatitis B integration site in hepatocellular carcinoma,Science 230: 319 – 322 (1985).CrossRefGoogle Scholar
  51. 51.
    Saracci, R., and Repetto, F., Time-trends of primary liver cancer: Indication of increased incidence in selected cancer registry populations,J. Natl Cancer Inst. 65: 241 – 247 (1980).Google Scholar
  52. 52.
    Schweitzer, I. L., Infection of neonates and infants with the hepatitis B virus,Prog. Med. Virol. 20: 27 – 48 (1975).Google Scholar
  53. 53.
    Shafritz, D. A., Shouval, D., Sherman, H. I., Hadziyannis, S. J., and Kew, M. C., Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens,N. Engl. J. Med. 305: 1067 – 1073 (1981).CrossRefGoogle Scholar
  54. 54.
    Sherlock, S.,Diseases of the Liver and Biliary System, 6th ed., Blackwell, Boston, 1981.Google Scholar
  55. 55.
    Stevens, C. E., Beasley, R. P., Tsui, J., and Lee, W. C., Vertical transmission of hepatitis B antigen in Taiwan,N. Engl. J. Med. 292: 771 – 774 (1975).CrossRefGoogle Scholar
  56. 56.
    Summers, J., Three recently described animal virus models for human hepatitis B virus,Hepatology 1: 179 – 183 (1981).CrossRefGoogle Scholar
  57. 57.
    Summers, J., Smolec, J. M., and Snyder, R., A virus similar to human hepatitis B virus associated with hepatitis and hepatoma in woodchucks,Proc. Natl. Acad. Sci. U.S.A. 75: 4533 – 4537 (1978).CrossRefGoogle Scholar
  58. 58.
    Sun, T.-T., Chu, Y.-R., Hsia, C.-C., Wei, Y.-P., and Wu, S.-M., Strategies and current trends of etiologic prevention of liver cancer,UCLA Symp. Mol. Cell. Biol. 40: 283 – 292 (1986).Google Scholar
  59. 59.
    Sun, T.-T., Chu, Y.-R., Ni, Z.-Q., Lu, J.-H., Huang, F., Ni, Z.-P., Pei, X.-F., Yu, Z.-I., and Liu, G.-T., A pilot study on universal immunization of newborn infants in an area of hepatitis B virus and primary hepatocellular carcinoma prevalence with a low dose of hepatitis B vaccine,J. Cell. Physiol. 4(Suppl.): 83 – 90 (1986).Google Scholar
  60. 60.
    Szmuness, W., Hepatocellular carcinoma and the hepatitis B virus: Evidence for a causal association,Prog. Med. Virol. 24: 40 – 69 (1978).Google Scholar
  61. 61.
    Szmuness, W., Stevens, C. E., Ikram, H., Much, M. I., Harley, E. J., and Hollinger, F. B., Prevalence of hepatitis B virus infection and hepatocellular carcinoma in Chinese-Americans,J. Infect. Dis. 137: 822 – 829 (1978).CrossRefGoogle Scholar
  62. 62.
    Tabor, E., Gerety, R. J., Vogel, C. L., Bayley, A. C., Anthony, P. P., Chan, C. H., and Barker, L. F., Hepatitis B virus infection and primary hepatocellular carcinoma,J. Natl. Cancer Inst. 58:1197–1200 (1977).Google Scholar
  63. 63.
    Tong, M. J., Thursby, M. W., Lin, J.-H., Weissman, J. V., and McPeak, C. M., Studies on the maternal–infant transmission of the hepatitis B virus and HBV infection within families,Prog. Med. Virol. 27: 137 – 147 (1981).Google Scholar
  64. 64.
    Twu, J.-S., and Schloemer, R. H., Transcriptionaltrans-activating function of hepatitis B virus,J. Virol. 61: 3448 – 3453 (1987).Google Scholar
  65. 65.
    Waterhouse, J., Muir, C., andCorrea, P. (eds.),Cancer Incidence in Five Continents, vol. 3, IARC Publication No. 15, IARC, Lyon, France, 1976.Google Scholar
  66. 65.
    Waterhouse, J., Muir, C., andCorrea, P. (eds.),Cancer Incidence in Five Continents, vol. 3, IARC Publication No. 15, IARC, Lyon, France, 1976.Google Scholar
  67. 67.
    Yaginuma, K., Kobayashi, H., Kobayashi, M., Morishima, T., Matsuyama, K., and Koike, K., Multiple integration site of hepatitis B virus DNA in hepatocellular carcinoma and chronic active hepatitis tissues from children, J.Virol 61: 1808 – 1813 (1987).Google Scholar
  68. 68.
    Yeh, F.-S., and Shen, K.-N., Epidemiology and early diagnosis of primary liver cancer in China,Adv. Cancer Res. 47: 297 – 329 (1986).CrossRefGoogle Scholar
  69. 69.
    Zhou, Y.-Z., Butel, J. S., Li, P.-J., Finegold, M. J., and Melnick, J. L., Integrated state of subgenomic fragments of hepatitis B virus DNA in hepatocellular carcinoma from mainland China,J. Natl. Cancer Inst. 79: 223 – 231 (1987).Google Scholar
  70. 70.
    Zhou, Y.-Z., Donehower, L. A., Slagle, B. L., van Tuinen, P., Ledbetter, D. H., and Butel, J. S., Hepatitis B virus DNA integration in chromosome 17p near the human p53 gene in a hepatocellular carcinoma, in:Abstracts of the Conference on Hepatitis B Viruses, p. 123, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1987.Google Scholar
  71. 71.
    Ziemer, M., Garcia, P., Shaul, Y., and Rutter, W. J., Sequence of hepatitis B virus DNA incorporated into the genome of a human hepatoma cell line,J. Virol. 53: 885 – 892 (1985).Google Scholar

Copyright information

© Plenum Publishing Corporation 1989

Authors and Affiliations

  • Joseph L. Melnick
    • 1
  1. 1.Department of Virology and EpidemiologyBaylor College of MedicineHoustonUSA

Personalised recommendations